Live Chart

O 363.65

H 363.65

L 363.65

VOL 20

Windlas Biotech Overview

Days Range

Low: ₹359.05
High: ₹369.50
Previous Close ₹360.10
Open ₹363.65
Volume 36,505
Day’s Range ₹359.05 - ₹369.50
52W Range ₹212.00 - ₹420.90
Market Cap ₹766.28 Cr

Fundamentals of Windlas Biotech

ROCE (TTM) 14.17%
P/E Ratio (TTM) 17.07
P/B Ratio 1.9
Industry P/E 32.55
Debt to Equity 0.01
ROE 10.59%
EPS (TTM) 21.1
Dividend Yield 1.09%
Book Value 189
Face Value 5

Financials of Windlas Biotech

Sep 2022Dec 2022Mar 2023Jun 2023
Net Sales132.73119.7140.71144.79
Expenses119.59108.89127.84130.83
Profit before tax15.6412.8215.0416.34
Operating Profit12.199.1911.4412.07
Net Profit12.199.1911.4412.07
EPS in Rs5.594.235.375.79

About Windlas Biotech

Windlas Biotech Ltd (formerly known as Windlas Biotech Private Limited) was incorporated in the year 2001. The Company provides pharmaceutical development services, large-scale manufacturing services ... Read More

Parent Organisation Indian Private
Founded 2001
Managing Director Vivek Dhariwal
NSE Symbol WINDLAS

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,321.53

283.95

4.20 (-1.46%)

282.8 - 296.6
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹51.58

46.65

0.25 (-0.53%)

46.65 - 46.65
Procter & Gamble Health Ltd ₹8,468.16

5084

16.35 (-0.32%)

5003.35 - 5103
Veerhealth Care Ltd ₹42.54

26

0.00 (0.00)

26 - 26

What's Trending

FAQs

What is the Share price of Windlas Biotech (WINDLAS)?

Windlas Biotech (WINDLAS) share price as of October 4, 2023, on NSE is Rs 366.55 (NSE) and Rs 367.20 (BSE) on BSE.

Can I buy Windlas Biotech (WINDLAS) shares?

Yes, You can buy Windlas Biotech (WINDLAS) shares by opening a Demat account with Angel One.

How do I buy Windlas Biotech (WINDLAS) from Angel One?

Windlas Biotech (WINDLAS) share can be brought through the following modes:
  1. Direct investment: You can buy Windlas Biotech (WINDLAS) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Windlas Biotech (WINDLAS) shares.